Coronary artery disease attack caused by cytotoxic chemotherapy

Ilveskoski, E.; Nikus, K.; Tanner, M.; Eskola, M.

Duodecim; Laaketieteellinen Aikakauskirja 125(9): 997-1001

2009


ISSN/ISBN: 0012-7183
PMID: 19517869
Document Number: 635976
Capesitabine is a orally administered cytotoxic drug metabolized to 5-fluorouracil and is widely used in large intestine cancer and breast cancer therapy. Its adverse effects against the heart have been considered to be rare. We describe four patients, who were diagnosed with an attack of coronary artery disease during capesitabine therapy on the basis of coronary spasm. This adverse effect should be kept in mind as a cause of chest pain symptoms and the medication discontinued in a suspected case.

Document emailed within 1 workday
Secure & encrypted payments